Here is the title one h1 placeholder text

On the evening of April 25, Guoen shares successfully completed the disclosure of the 2022 annual report. In 2022, the company seized the opportunity, worked hard, and achieved a new level of operating performance: revenue of 13.406 billion yuan, a year-on-year increase of 37.28, a record high.

In 2022, in the face of a severe and complex external environment and economic situation, the company will give full play to the advantages of a vertically integrated industrial platform to carry out a dot-matrix industrial layout in Qingdao, Rizhao, Shandong, and coastal provinces and cities such as Jiangsu, Zhejiang, and Guangdong. The coordinated efforts of all sectors of the big health industry have driven the overall performance to record highs.

Integration of new chemical materials to speed up the layout

In 2022, in the face of the trillion blue ocean of the new chemical materials industry, the company continues to extend the chain, complement the chain, strong chain, speed up the vertical integration layout.

In the green petrochemical materials sector, subsidiary Zhejiang YI Plastic is under construction with an annual outputThe first phase of the 1 million-ton polystyrene project has been initially put into production, and the second phase of the project is being steadily implemented. After the project is fully completed, it will become the world's largest polystyrene monomer production plant; the subsidiary Jiangsu Guoheng has an annual output of 200000 tons. Polypropylene (PP) resin production capacity has been fully put into production, and product sales have steadily increased. The establishment of Rizhao Guoen Chemical will further enhance the scale advantages of upstream and downstream integration, improve product market competitiveness, and lay a solid foundation for the comprehensive construction of the spatial pattern of large chemical and fine chemical industries. At present, Rizhao Guoen Chemical has an annual production capacity of 120000 tons of expandable polystyrene (EPS), and plans to further expand its production capacity in the future.

In the polymer modified material plate,In 2022, the company has gradually realized the upgrade from a single modified plastic to a variety of new chemical materials, and the product structure continues to extend to the high-end and high value-added direction, covering home appliances and automotive modified materials, new energy industry materials, degradable materials, light display materials, artificial turf, meltblown materials, medical protection materials, etc. In the field of consumption, the company has made new breakthroughs in business layout and customer expansion, successfully entered the field of building materials industry, reached strategic cooperation with the main enterprises in the new infrastructure industry chain, and successfully developed projects such as building template materials, advanced template support and reinforcement system and standardized process templates. The company's template material technology is at the leading level in the industry, and the supply volume continues to rise.

In the organic polymer composite material sector, the company digs deep into the application scenarios of composite materials, effectively solves customers' demands for materials, explores diversified applications in various fields, focuses on the direction of the new energy automobile industry chain, and makes efforts in the new energy composite material chocolate ultra-thin (HP-RTM) Battery pack, new energy vehicle charging pile, passenger car battery box, pantograph, smart light pole, wind power, rail transit and other fields continue to break through. In 2022, the company will focus on developing and HP-RTM the application of pre-forming, glue injection, laser cutting, air tightness inspection and other related processes in new energy composite chocolate ultra-thin battery packs, and has established strategic cooperation with new energy power battery head enterprises to carry out fixed-point layout in the field of new composite materials, which will become an important pole of the company's composite material plate in the future.

Big health industry to achieve leapfrog growth

In 2022, galloping on the promising big healthy track, the company has realized the two wings of To B- end business and To C- end business, making new breakthroughs in terminal business and achieving leapfrog growth in performance.

To B- side overall market demand is good, the company's subsidiary Dongbao biological full range of products to achieve year-on-year revenue growth, the core scale advantage highlighted. The sales revenue of gelatin series products increased by 14.60 year-on-year, a record high; the sales revenue of raw material collagen increased by 58.91 year-on-year, and the scale advantage was further expanded. At the same time, Dongbao Bio subsidiary Yiqing Bio is making every effort to promote project construction and expand production capacity.

In the domestic market, the company has successfully opened up a number of new customers for gelatin, collagen and hollow capsules, expanded the application of products to hot pot condiment, medical devices, flavor and explosive beads and other fields, and realized the sales of pharmacopoeia II gelatin. Suzhou Braun, as the star customer of pharmacopoeia II gelatin, has established the company's first-mover advantage in the field of medical collagen and developed medical treatment for the future.(therapy) and other high value-added markets to lay the foundation.

In the international market, the company actively integrates market resources, establishes an international trade department, and sets up domestic and international trade offices in Hangzhou, Qingdao and other places to integrate with the multi-point layout of terminal business, and enhance trade business through resource and channel sharing.In 2022, the company's export business will be further improved and new breakthroughs will be achieved, laying a good foundation for the rapid development of the subsequent export business and the internationalization of the main business.

The To C- side business is the company's future focus. In 2022, Dongbao Bio anchors the broad big health market and the good application prospect of collagen in the big health market, continues to promote product upgrades, vigorously promotes the multi-point layout of the terminal business, and steadily promotes the landing of the "collagen" strategy, thus achieving a new breakthrough in the terminal business.

In terms of product layout, the company continues to enrich the product matrix, and has launched a series of bovine bone collagen peptide powder, composite probiotic solid drinks, meal replacement shakes, collagen hydration.New products such as bright color mask, bird's nest collagen peptide liquid drink, passion fruit enzyme powder solid drink, mouth fragrance explosive beads, etc., cover the fields of immunity enhancement, bone health, oral health, intestinal health, oral beauty, etc., and optimize the price system to better meet the market demand.

In terms of brand promotion, the company"grassland fresh bovine bone · small molecule · collagen peptide" as the breakthrough point, to create a well-known brand of national collagen. Invite film and television actors to speak for the Yuansu brand, invite well-known online celebrities to carry out live delivery, continuously improve product attention, convey to consumers the brand concept of "collagen health" and the brand vision of "dedicated to collagen serving human health", enrich the brand image, enhance brand awareness and consumer loyalty.

In terms of channel construction, on the one hand, the company increased the promotion of the original online and offline channels, on the other hand, it built in Hangzhou, Qingdao and other relatively developed areas of the Internet.To C has its own new private domain e-commerce platform, set up subsidiaries Guoen Jingtao and Dongbao Yuansu, and set up a professional team specializing in the marketing and promotion of terminal series products. In addition, the company also vigorously develop group purchase business, and actively develop OEM business.

In 2022, Guoen Group will actively implement the strategic layout of the industrial chain through "two wings with the same frequency drive, endogenous extension and development", and achieve brilliant results. In the future, the company will continue to practice the strategic development model of vertical integration of industries, extend the industrial chain, open up the supply chain, enhance the value chain, build an ecological chain, and continue to deepen the construction of a "one body and two wings" vertical integration with large chemical industry and large health industry as two wings. Industrial platform, continue to achieve high-quality, leapfrog development of Guoen Group!